Amgen vs. Vertex Pharmaceuticals: Value Stability vs. High-Growth Biotech Investment Plays Sep 14, 2026 Life Science
Druckenmiller’s $613 Million Silent Bet Is Crushing Nvidia — and It’s Not a Tech Stock Jul 16, 2026 Life Science
Vertex’s $10 Billion Crinetics Acquisition Lands Amid Record Stock High: Time to Buy? Jul 8, 2026 Life Science
Merck KGaA’s $11.3 Billion Bio-Techne Buy Bolsters CGT Ambitions in Biggest Deal Since 2014 Jun 25, 2026 Life Science
AI Rewrites Drug Discovery: Eli Lilly and Twist Bioscience Chart Two Distinct Industrialization Paths Jun 19, 2026 Life Science, Technology
Why CRISPR Therapeutics Stock Is Stuck Despite Boasting the World’s First Approved CRISPR Therapy Jun 18, 2026 Life Science
